ArticleClinical and translational medicine2026
TMEM59L promotes neuroendocrine differentiation and enzalutamide resistance in prostate cancer by regulating MUC1/β-catenin/MYC axis.
Xiuchen Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.